DINOL and sarcoma: The spectrum of spontaneous tumors in Dino−/− mice reflects human cancers in which DINO hypermethylation and TP53 mutations are mutually exclusive and was consistent with our prior results that loss of Dino enhanced oncogene-induced tumorigenesis in B cell and sarcoma [17].